MAR 24, 2016 8:08 AM PDT

Scientists Create ‘Smarter' Insulin Patch to Control Diabetes

WRITTEN BY: Xuan Pham
Microneedle-array patch filled with live beta cells

For patients with diabetes, managing their blood sugar levels requires constant care and vigilance. To make regulating the insulin levels easier and less painful, scientists have produced a ‘smart’ insulin patch filled with beta cells that can sense blood sugar levels and secrete insulin as needed.
 
The study was published in Advanced Materials by a team from the University of North Carolina at Chapel Hill and North Carolina State University. The basis of their innovation was a patch made of synthetic polymers that are covered in tiny nanoscale microneedles, which they developed as a proof-of-principle last year. In the latest improved version, the needles on the patch are filled with actual live beta cells instead of an insulin solution.
 
"This study provides a potential solution for the tough problem of rejection, which has long plagued studies on pancreatic cell transplants for diabetes," said Zhen Gu, assistant professor in the joint UNC/NC State department of biomedical engineering and senior study author. "Plus it demonstrates that we can build a bridge between the physiological signals within the body and these therapeutic cells outside the body to keep glucose levels under control."
 
 
Insulin is a hormone produced naturally in the body that stimulates the uptake of glucose in the body’s cells. In diabetes there is a deficiency of insulin, either because beta cells in the pancreas are unable to produce insulin (Type 1 diabetes), or the normal insulin is produced in insufficiently quantities (Type 2 diabetes). Both forms of diabetes require external insulin therapy, as without insulin glucose levels can rise dangerously high and can affect many other cellular functions of the body.
 
Though it may sound painful – a patch with hundreds of needles poking out – the device is about the size of a quarter, and the microneedles are about the diameter of an eyelash. The needles are necessary to connect the patch to the internal blood vessels of the body. And each of these needles contains thousands of live beta cells encapsulated in a alginate mixture. The patch also contains “glucose-signal amplifers” – chemical megaphones that relay crucial blood sugar levels to the insulin-producing beta cells.
 
In studies using type-1 diabetic mice, the researchers found the patch released insulin in response to increased blood glucose levels in 10 hour intervals. To demonstrate the patch is ‘smart’ and can sense when NOT to release insulin, researchers applied a second patch. As expected, insulin was not released in excess, and the glucose levels in the mice stabilized for a total of 20 hours.
 
That the patch can sense and regulate insulin release is a huge advantage of this live cell system. This means there’s no danger of insulin over-dose, which would result in excessively low blood sugar (hypoglycemia), an equally dangerous condition for diabetics. "Managing diabetes is tough for patients because they have to think about it 24 hours a day, seven days a week, for the rest of their lives," said John Buse, professor of medicine at the UNC School of Medicine and co-author of the study. "These smart insulin approaches are exciting because they hold the promise of giving patients some time off with regards to their diabetes self-care. It would not be a cure but a desperately needed vacation," he added.
 
Additional source: UNC press release
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 14, 2021
Clinical & Molecular DX
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
APR 14, 2021
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
A patient undergoes chemotherapy and radiation for rectal cancer. How do doctors know whether all the malignant tissue h ...
APR 27, 2021
Clinical & Molecular DX
No Batteries: Health Sensor Harvests Biomechanical Energy
APR 27, 2021
No Batteries: Health Sensor Harvests Biomechanical Energy
An international team of researchers has developed a wearable health monitor that works without the need for batteries. ...
MAY 10, 2021
Clinical & Molecular DX
Noninvasive Device Warns When Wounds Are Bleeding
MAY 10, 2021
Noninvasive Device Warns When Wounds Are Bleeding
Patients with kidney failure have to undergo hemodialysis—a process where a dialysis machine takes the place of ki ...
JUL 06, 2021
Clinical & Molecular DX
Undiagnosed Dementia Much More Prevalent Than Previously Thought
JUL 06, 2021
Undiagnosed Dementia Much More Prevalent Than Previously Thought
An analysis of data from the Health and Retirement Study has yielded a startling revelation: 91 percent of people experi ...
AUG 05, 2021
Clinical & Molecular DX
Gene Markers in Mothers Point to the Risk of Preterm Birth
AUG 05, 2021
Gene Markers in Mothers Point to the Risk of Preterm Birth
Preterm births—when the baby is born fewer than 37 weeks gestational age—are very common. Experts estimate o ...
SEP 09, 2021
Clinical & Molecular DX
A Drug Test for Synthetic Cannabis Use
SEP 09, 2021
A Drug Test for Synthetic Cannabis Use
Designer drugs are synthetic analogs of prohibited substances such as cocaine and LSD made in clandestine laboratories a ...
Loading Comments...